The Rapidly Changing Treatment Landscape of Systemic Therapy for HER-2 Positive Metastatic Breast Cancer
Human epidermal growth factor receptor 2 (HER-2) overexpressed breast cancer has traditionally been considered as an aggressive disease with high risk of systemic and brain metastases and poor prognosis. Nowadays, we have many HER-2 targeting treatments that have radically changed patients’ outcomes...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
THE HEALTHBOOK COMPANY LTD.
2021-10-01
|
| Series: | healthbook TIMES. Oncology Hematology |
| Online Access: | https://healthbook-times.scholasticahq.com/article/29070-the-rapidly-changing-treatment-landscape-of-systemic-therapy-for-her-2-positive-metastatic-breast-cancer.pdf |